Skip to Content

Maxzide-25 Side Effects

Generic Name: hydrochlorothiazide / triamterene

Note: This page contains information about the side effects of hydrochlorothiazide / triamterene. Some of the dosage forms included on this document may not apply to the brand name Maxzide-25.

For the Consumer

Applies to hydrochlorothiazide / triamterene: oral capsule, oral tablet

In addition to its needed effects, some unwanted effects may be caused by hydrochlorothiazide / triamterene. In the event that any of these side effects do occur, they may require medical attention.

Severity: Major

You should check with your doctor immediately if any of these side effects occur when taking hydrochlorothiazide / triamterene:

Incidence not known:
  • Abdominal or stomach pain
  • agitation
  • back or leg pains
  • black, tarry stools
  • bleeding gums
  • blisters, hives, or itching
  • bloating
  • blood in the urine or stools
  • blue lips and fingernails
  • blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • chest pain
  • chills
  • clay-colored stools
  • cloudy urine
  • cold sweats
  • coma
  • confusion
  • constipation
  • convulsions
  • cough or hoarseness
  • coughing that sometimes produces a pink frothy sputum
  • dark urine
  • decreased urine output
  • depression
  • difficult, fast, noisy breathing, sometimes with wheezing
  • difficulty swallowing
  • dizziness, faintness, or lightheadedness when getting up from lying or sitting position
  • drowsiness
  • dry mouth
  • fast, slow, or irregular heartbeat
  • fever with or without chills
  • flushed, dry skin
  • fruit-like breath odor
  • general body swelling
  • general feeling of discomfort, illness, or weakness
  • greatly decreased frequency of urination or amount of urine
  • headache
  • hostility
  • incoherent speech
  • increased hunger
  • increased sweating
  • increased thirst
  • increased urination
  • indigestion
  • irritability
  • joint pain, stiffness, or swelling
  • lethargy
  • loss of appetite
  • loss of consciousness
  • lower back or side pain
  • metallic taste
  • mood changes
  • muscle pain, cramps, weakness, or twitching
  • nausea or vomiting
  • nervousness
  • nosebleeds
  • numbness or tingling in the hands, feet, or lips
  • pain in the groin or genitals
  • painful or difficult urination
  • pains in the stomach, side, or abdomen, possibly radiating to the back
  • pale skin
  • pinpoint red or purple spots on the skin
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • rapid weight gain
  • seizures
  • sharp back pain just below the ribs
  • shortness of breath
  • skin rash
  • sore throat
  • sores, ulcers, or white spots on the lips or in the mouth
  • stomachache
  • stupor
  • sugar in the urine
  • swelling of the face, ankles, hands, feet, or lower legs
  • swollen or painful glands
  • thickening of bronchial secretions
  • tightness in the chest
  • troubled breathing
  • unexplained weight loss
  • unpleasant breath odor
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • vomiting of blood
  • weak pulse
  • weakness or heaviness of the legs
  • wheezing
  • yellow eyes or skin

If any of the following symptoms of overdose occur while taking hydrochlorothiazide / triamterene, get emergency help immediately:

Symptoms of overdose:
  • Face is warm or hot to touch
  • frequent urination
  • increased volume of pale, dilute urine
  • loss of strength or energy
  • pain or weakness in the hands or feet
  • redness to face
  • reflexes are unusually strong
  • trembling

Severity: Minor

Some of the side effects that can occur with hydrochlorothiazide / triamterene may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Incidence not known:
  • Decreased interest in sexual intercourse
  • feeling of constant movement of self or surroundings
  • inability to have or keep an erection
  • increased sensitivity of the skin to sunlight
  • loss in sexual ability, desire, drive, or performance
  • redness or other discoloration of the skin
  • sensation of spinning
  • severe sunburn
  • welts

For Healthcare Professionals

Applies to hydrochlorothiazide / triamterene: oral capsule, oral tablet


Hydrochlorothiazide (HCTZ)-triamterene is generally well-tolerated, especially in patients with adequate urine output. Serious side effects have been reported in less than 0.1% of patients.[Ref]


Patients with sulfa sensitivity may develop an allergic reaction to drugs containing hydrochlorothiazide.[Ref]

Hypersensitivity reactions include rare cases of drug fever, anaphylaxis, photosensitive dermatitis, and erythema multiforme. Cases of acute pulmonary edema, interstitial cystitis, and interstitial nephritis have been associated with HCTZ.[Ref]


A 67-year-old white woman with hypothyroidism, hypercalcemia, depression, and hypertension developed facial erythema, headaches, tremors, confusion, and personality changes associated with a new positive ANA and anti-nRNP, and a skin biopsy consistent with lupus erythematosus while taking hydrochlorothiazide (HCTZ), levothyroxine, and amitriptyline. The eruption resolved upon discontinuation of HCTZ, but she later developed a higher ANA titer associated with symptomatic diffuse interstitial pulmonary infiltrates. She was successfully treated with corticosteroids.[Ref]

Dermatologic reactions include case reports of erythema annular centrifugum, acute eczematous dermatitis, and morbilliform or leukocytoclastic vasculitis. Thiazides may induce phototoxic dermatitis. In addition, a rare, distinct entity with clinical and laboratory features indistinguishable from those of subacute cutaneous lupus erythematosus has been associated with HCTZ.

Postmarketing reports of dermatologic reactions have included Stevens-Johnson syndrome and exfoliative dermatitis, including toxic epidermal necrolysis.[Ref]


Cardiovascular side effects include hypotension, orthostatic hypotension, and cardiac arrhythmias. Arrhythmias have been associated with HCTZ-induced hypokalemia; hypokalemia is much less likely with the addition of triamterene. See "metabolic" side effects below.[Ref]


The presence of an arrhythmia or widened QRS complex associated with hyperkalemia requires prompt administration of 10% calcium gluconate 10 to 20 mL intravenously over a 20 to 30 minute interval. Noncardiotoxic hyperkalemia usually responds to 10 units of regular insulin plus glucose 25 grams (as a 20% solution infused over 30 minutes) and consideration of sodium bicarbonate 40 to 150 mEq infused over a 30 to 60 minute interval. Insulin-dependent diabetic patients with preexisting hyperglycemia may not require the glucose infusion.

Since hydrochlorothiazide may increase total serum cholesterol by 11%, LDL lipoprotein cholesterol by 12%, and VLDL lipoprotein cholesterol levels by 50%, and may reduce insulin secretion, it is recommended that hydrochlorothiazide be used with caution in patients with hypercholesterolemia or diabetes. A case of hyperosmolar hyperglycemic coma is associated with hydrochlorothiazide.

Hyperuricemia may be an important consideration in patients with a history of gout. Hypophosphatemia and hypomagnesemia may occur, but are usually clinically insignificant except in malnourished patients.[Ref]

Metabolic abnormalities include acidosis and hyperkalemia, which is more likely in the elderly, diabetic, or renally insufficient. It is recommended that serum potassium concentrations be monitored, and an electrocardiogram be obtained if hyperkalemia is suspected to check for peaked T waves and QRS complex changes.

Hyponatremia, hypokalemia, hypercalcemia, hyperglycemia, and elevated serum uric acid and cholesterol levels have been associated with hydrochlorothiazide.[Ref]


Gastrointestinal side effects, such as nausea and vomiting, may be lessened by administering the drug after meals. Due to the diuretic action of the drug some patients complain of dry mouth.[Ref]

Rare cases of pancreatitis associated with the combination drug have been reported. Thiazide diuretics may increase serum cholesterol and triglycerides, resulting in increased risk of cholesterol gallstone formation. Reports of bowel strictures associated with thiazide ingestion are reported in the 1960's, although these patients were on a combination hydrochlorothiazide-potassium product.[Ref]


Hepatic side effects are rare. A case of cholestatic jaundice and centrilobular necrosis of the liver has been associated with triamterene (probably related to hypersensitivity to the drug). Triamterene may cause a spurious elevation in serum lactate dehydrogenase concentrations.[Ref]


A case of obstructive renal tubular triamterene calculi is reported. Triamterene is less soluble in solutions with a pH less than 6.0. In addition, triamterene alone, and when combined with hydrochlorothiazide, is associated with acute interstitial nephritis and acute renal failure in rare cases.[Ref]

Renal side effects including new or worsened renal insufficiency has been reported in less than 1% of patients. Triamterene renal calculi has been estimated to occur in 1/1,500 to 1/2,000 patients. Rare cases of interstitial nephritis and bladder calculi have been reported.[Ref]


Hematologic side effects include thrombocytopenia and macrocytic anemia.[Ref]

Rare cases of triamterene-induced dose-dependent hemagglutination resulting in acute intravascular hemolysis are reported. Hydrochlorothiazide-associated immune-complex hemolytic anemia and aplastic anemia are reported.

Triamterene inhibits dihydrofolate reductase, resulting in decreased folate production. This may be important in patients who have borderline folate stores, such as pregnant women and alcohol abusers.[Ref]


Musculoskeletal side effects include myalgias.[Ref]

Nervous system

Rare cases of cerebrovascular insufficiency are associated with hydrochlorothiazide-induced plasma volume contraction.[Ref]

Nervous system side effects include fatigue and headache.[Ref]


Endocrinologic problems associated with thiazide diuretics include glucose intolerance and a potentially deleterious effect on the lipid profile. This may be important in some patients with or who are at risk for diabetes or coronary artery disease. A single case of recurrent parathyroid adenoma has been associated with HCTZ, although the association was probably coincidental.[Ref]

A prospective study of 34 patients who received oral thiazide diuretics for 14 years without interruption revealed an increased average fasting blood glucose level after treatment. Withdrawal of thiazide therapy for seven months in 10 of the patients resulted in average reductions of 10% in fasting blood glucose and 25% in the 2-hour glucose tolerance test value. A control group was not reported.[Ref]


A laboratory abnormality associated with triamterene is spurious elevation of lactate dehydrogenase concentrations. Triamterene interferes with the fluorescent measurement of quinidine, resulting in erroneous values of the serum quinidine concentration.[Ref]


Respiratory side effects have rarely been associated with HCTZ. Some cases of acute pulmonary edema were thought to be due to idiosyncrasy or hypersensitivity to the drug.[Ref]


Ocular side effects including acute transient myopia with shallowing of the anterior chamber has rarely been associated with HCTZ-triamterene, HCTZ, chlorthalidone, trichlormethiazide, and other sulfonamides, as well as aspirin, ethoxzolamide and acetazolamide. Ocular side effects have also included idiosyncratic reactions to the hydrochlorothiazide component resulting in acute transient myopia and acute angle-closure glaucoma.[Ref]

Transient myopia with anterior chamber flattening and choroidal detachment has been associated with hydrochlorothiazide-triamterene. Other mechanisms that have been proposed or described include (a) spasm of accommodation, (b) changes in lens structure resulting from altered sodium chloride metabolism, (c) edema of the ciliary body (which produces increased curvature of the lens surface), (d) inhibition of fluid by the lens, (e) increased lenticular index of refraction because of dry salt retention, (f) changes in the refractive index of the vitreous and aqueous because of differential sugar levels, and (h) stretching of the sclera.[Ref]


1. Hoss DM, Nierenberg DW "Severe shaking chills and fever following hydrochlorothiazide administration." Am J Med 85 (1988): 747

2. Hollenberg NK, Mickiewicz CW "Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide) [published erratum appears in Am J Cardiol 1990 Aug 1;66(3):388]." Am J Cardiol 63 (1989): b37-41

3. Nolan PJ, D'Arcy G "Triamterene drug fever and hepatitis ." Med J Aust 147 (1987): 262

4. Safdi MA "Fever secondary to triamterene therapy ." N Engl J Med 303 (1980): 701

5. Grace AA, Morgan AD, Strickland NH "Hydrochlorothiazide causing unexplained pulmonary oedema." Br J Clin Pract 43 (1989): 79-81

6. Alted E, Navarro M, Cantalapiedra JA, Alvarez JA, Blasco MA, Nunez A "Non-cardiogenic pulmonary edema after oral ingestion of hydrochlorothiazide ." Intensive Care Med 13 (1987): 364-5

7. Klein MD "Noncardiogenic pulmonary edema following hydrochlorothiazide ingestion." Ann Emerg Med 16 (1987): 901-3

8. Fernandez de Corres L, Bernaola G, Fernandez E, Leanizbarrutia I, Munoz D "Photodermatitis from triamterene." Contact Dermatitis 17 (1987): 114-5

9. Hoegholm A, Rasmussen SW, Kristensen KS "Pulmonary oedema with shock induced by hydrochlorothiazide: a rare side effect mimicking myocardial infarction." Br Heart J 63 (1990): 186

10. Levay ID "Hydrochlorothiazide-induced pulmonary edema." Drug Intell Clin Pharm 18 (1984): 238-9

11. Eitzen AC "Report of a death following administration of triamterene." J Kans Med Soc 67 (1966): 454-5

12. Breathnach SM, Dutt MK, Black MM "A severe bullous eruption occurring in a patient with chronic active hepatitis and glomerulonephritis." Arch Dermatol 116 (1980): 1061-3

13. Dorn MR, Walker BK "Noncardiogenic pulmonary edema associated with hydrochlorothiazide therapy." Chest 79 (1981): 482-3

14. Biron P, Dessureault J, Napke E "Acute allergic interstitial pneumonitis induced by hydrochlorothiazide [published erratum appears in Can Med Assoc J 1991 Sep 1;145(5):391]." Can Med Assoc J 145 (1991): 28-34

15. Diffey BL, Langtry J "Phototoxic potential of thiazide diuretics in normal subjects." Arch Dermatol 125 (1989): 1355-8

16. Goodrich AL, Kohn SR "Hydrochlorothiazide-induced lupus erythematosus: a new variant?" J Am Acad Dermatol 28 (1993): 1001-2

17. Parodi A, Romagnoli M, Rebora A "Subacute cutaneous lupus erythematosus-like eruption caused by hydrochlorothiazide." Photodermatol 6 (1989): 100-2

18. Papademetriou V, Fletcher R, Khatri IM, Freis ED "Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias." Am J Cardiol 52 (1983): 1017-22

19. Holland OB, Kuhnert L, Pollard J, Padia M, Anderson RJ, Blomqvist G "Ventricular ectopic activity with diuretic therapy." Am J Hypertens 1 (1988): 380-5

20. Hollifield JW, Slaton PE "Thiazide diuretics, hypokalemia and cardiac arrhythmias." Acta Med Scand Suppl 647 (1981): 67-73

21. Ragnarsson J, Hardarson T, Snorrason SP "Ventricular dysrhythmias in middle-aged hypertensive men treated either with a diuretic agent or a beta-blocker." Acta Med Scand 221 (1987): 143-8

22. Mouallem M, Friedman E, Shemesh Y, Mayan H, Pauzner R, Farfel Z "Cardiac conduction defects associated with hyponatremia." Clin Cardiol 14 (1991): 165-8

23. Ettinger B, Oldroyd NO, Sorgel F "Triamterene nephrolithiasis." JAMA 244 (1980): 2443-5

24. Hollenberg NK, Mickiewicz C "Hyperkalemia in diabetes mellitus. Effect of a triamterene- hydrochlorothiazide combination." Arch Intern Med 149 (1989): 1327-30

25. Hansen KB, Bender AD "Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination." Clin Pharmacol Ther 8 (1967): 392-9

26. Walker BR, Capuzzi DM, Alexander F, Familiar RG, Hoppe RC "Hyperkalemia after triamterene in diabetic patients." Clin Pharmacol Ther 13 (1972): 643-51

27. Petersen AG "Letter: Dyazide and hyperkalemia." Ann Intern Med 84 (1976): 612-3

28. Amery A, Berthaux P, Bulpitt C, Deruyttere M, de Schaepdryver A, Dollery C, Fagard R, Forette F, Hellemans J, Lund-Johansen PMutsers A, Tuomilehto J "Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly." Lancet 1 (1978): 681-3

29. Polanska AI, Baron DN "Hyponatraemia associated with hydrochlorothiazide treatment ." Br Med J 1 (1978): 175-6

30. Byatt CM, Millard PH, Levin GE "Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions." J R Soc Med 83 (1990): 704-8

31. Berlin I "Prazosin, diuretics, and glucose intolerance." Ann Intern Med 119 (1993): 860

32. Murphy MB, Kohner E, Lewis PJ, Schumer B, Dollery CT "Glucose intolerance in hypertensive patients treated with diuretics: a fourteen-year follow-up." Lancet 2 (1982): 1293-5

33. Seelig CB "Magnesium deficiency in two hypertensive patient groups." South Med J 83 (1990): 739-42

34. Macleod MD, Bell GM, Irvine WJ "Nephrogenic diabetes insipidus associated with Dyazide (triamterene- hydrochlorothiazide)." Br Med J (Clin Res Ed) 283 (1981): 1155-6

35. Fager G, Berglund G, Bondjers G, Elmfeldt D, Lager I, Olofsson SO, Smith U, Wiklund O "Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide." Artery 11 (1983): 283-96

36. Cohen AB "Hyperkalemic effects of triamterene." Ann Intern Med 65 (1966): 521-7

37. Klimiuk PS, Davies M, Adams PH "Primary hyperparathyroidism and thiazide diuretics." Postgrad Med J 57 (1981): 80-3

38. Schnaper HW, Maxwell MH "Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension [published erratum appears in Am J Cardiol 1990 Aug 1;66(3):388]." Am J Cardiol 63 (1989): b32-6

39. Benfield GF, Haffner C, Harris P, Stableforth DE "Dilutional hyponatraemia masquerading as subarachnoid haemorrhage in patient on hydrochlorothiazide/amiloride/timolol combined drug ." Lancet 2 (1986): 341

40. Roberts CJ, Channer KS, Bungay D "Hyponatraemia induced by a combination of hydrochlorothiazide and triamterene." Br Med J (Clin Res Ed) 288 (1984): 1962

41. Carr MC, Prien EL, Jr Babayan RK "Triamterene nephrolithiasis: renewed attention is warranted." J Urol 144 (1990): 1339-40

42. Dooley DP, Callsen ME, Geiling JA "Triamterene nephrolithiasis." Mil Med 154 (1989): 126-7

43. Bain PG, Egner W, Walker PR "Thiazide-induced dilutional hyponatraemia masquerading as subarachnoid haemorrhage ." Lancet 2 (1986): 634

44. Jick H, Dinan BJ, Hunter JR "Triamterene and renal stones." J Urol 127 (1982): 224-5

45. Pinnock CA "Hyponatraemia associated with hydrochlorothiazide treatment ." Br Med J 1 (1978): 48

46. Carey RA, Beg MM, McNally CF, Tannenbaum P "Triamterene and renal lithiasis: a review." Clin Ther 6 (1984): 302-9

47. Bell DS "Insulin resistance. An often unrecognized problem accompanying chronic medical disorders." Postgrad Med 93 (1993): 99-103,

48. Reinus FZ, Weinberger HA, Fischer WW "Medication-induced ulceration of the small bowel." Am J Surg 112 (1966): 97-101

49. Cocke T, Fisch S, Gilmore H, Okun R, Tamagna I, Wipplinger K "Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension." J Clin Pharmacol 17 (1977): 334-8

50. Bender AD, Carter CL, Hansen KB "Use of a diuretic combination of triamterene and hydrochlorothiazide in elderly patients." J Am Geriatr Soc 15 (1967): 166-73

51. Dietz MW "Iatrogenic jejunal ulcer." Am J Roentgenol Radium Ther Nucl Med 99 (1967): 136-8

52. Chainuvati T, Harinasuta U, Zimmerman HJ "Spurious elevation of apparent lactate dehydrogenase activity caused by triamterene." Clin Chem 19 (1973): 1202-4

53. Wagner W, Longerbeam JK, Smith LL, Feikes HL "Drug-induced ulcers of the small bowel causing intestinal obstruction or perforation." Am Surg 33 (1967): 7-11

54. Hollander JB "Triamterene bladder calculus." Urology 30 (1987): 154-5

55. Patel KM "Triamterene nephrolithiasis complicating dyazide therapy." J Urol 126 (1981): 230

56. White DJ, Nancollas GH "Triamterene and renal stone formation." J Urol 127 (1982): 593-7

57. Grunberg RW, Silberg SJ "Triamterene-induced nephrolithiasis." JAMA 245 (1981): 2494-5

58. Ettinger B, Weil E, Mandel NS, Darling S "Triamterene-induced nephrolithiasis." Ann Intern Med 91 (1979): 745-6

59. "Triamterene and the kidney." Lancet 1 (1986): 424

60. Bailey RR, Lynn KL, Drennan CJ, Turner GA "Triamterene-induced acute interstitial nephritis." Lancet 1 (1982): 226

61. Werness PG, Bergert JH, Smith LH "Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites." J Lab Clin Med 99 (1982): 254-62

62. Fairley KF, Woo KT, Birch DF, Leaker BR, Ratnaike S "Triamterene-induced crystalluria and cylinduria: clinical and experimental studies." Clin Nephrol 26 (1986): 169-73

63. Roy LF, Villeneuve JP, Dumont A, Dufresne LR, Duran MA, Morin C, Jobin J "Irreversible renal failure associated with triamterene." Am J Nephrol 11 (1991): 486-8

64. Socolow EL "Triamterene-induced nephrolithiasis ." Ann Intern Med 92 (1980): 437

65. Dickstein ES, Loeser WD "Triamterene calculus." J Urol 133 (1985): 1019

66. Spence JD, Wong DG, Lindsay RM "Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazide." Lancet 2 (1985): 73-5

67. Gault MH, Snedden W, Taor RE, Churchill DN, Ahmed M "Triamterene urolithiasis." Can Med Assoc J 124 (1981): 1556-7

68. Takahashi H, Tsukada T "Triamterene-induced immune haemolytic anaemia with acute intravascular haemolysis and acute renal failure." Scand J Haematol 23 (1979): 169-76

69. Lieberman FL, Bateman JR "Megaloblastic anemia possibly induced by triamterene in patients with alcoholic cirrhosis. Two case reports." Ann Intern Med 68 (1968): 168-73

70. Corcino J, Waxman S, Herbert V "Mechanism of triamterene-induced megaloblastosis." Ann Intern Med 73 (1970): 419-24

71. Hubbard JR, Levenson JL, Patrick GA "Psychiatric side effects associated with the ten most commonly dispensed prescription drugs: a review." J Fam Pract 33 (1991): 177-86

72. Balizet L "Recurrent parathyroid adenoma. Association with prolonged thiazide administration." JAMA 225 (1973): 1238-9

73. "Product Information. HydroDIURIL (hydrochlorothiazide)." Merck & Co, Inc, West Point, PA.

74. Soylev MF, Green RL, Feldon SE "Choroidal effusion as a mechanism for transient myopia induced by hydrochlorothiazide and triamterene." Am J Ophthalmol 120 (1995): 395-7

Not all side effects for Maxzide-25 may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.